Presenter: Dr. David Margolis Sarah Graham Kenan Distinguished Professor of Medicine, Microbiology & Immunology, Epidemiology Director, UNC HIV Cure Center
Although current therapy for HIV infection can be safe, simple, and durable, the burden of decades of continuous therapy remains, with the stigma and uncertainty of chronic HIV infection. Although current antiretroviral therapy (ART) can nearly eliminate viremia in patients with HIV infection, a small population of long-lived CD4+ T cells remains persistently infected and unrecognized by the immune system, with minimal expression of HIV genes or proteins. The persistence of quiescent HIV infection is a major obstacle to eradication and cure of HIV infection. New therapeutic approaches to this quiescent or latent state of HIV infection are needed. This presentation discusses research towards an HIV cure.
No Accreditation for Recorded or Archived events.
Largely clinical staff including attending physicians, nurses, fellows, and mental health providers.
A variety of the listed populations will be discussed at this event.
Children (ages 0 to 12)
Adolescents (ages 13 to 17)
Young Adults (ages 18 to 24)
Older Adults (ages 50 and over)
American Indian or Alaska Native
Black or African American
Hispanic or LatinX
Native Hawaiian or Pacific Islander
Gay, lesbian, bisexual
Transgender, Non-Binary, Other Gender
People Experiencing Homlessness
People with Incarceration Experience
Immigrants or Refugees
U.S. Mexico border population
People Who Inject Drugs (PWID)
Other special population
A variety of the listed topics will be discussed at this event.
Antiretroviral treatment adherence, including viral load suppression